Alison Armour

Company: CURADH Pharmaceuticals

Job title: Founder Curadh pharmaceuticals

Seminars:

Designing the Next Generation of Molecularly Targeted Radiotherapies (MTRs) 12:00 pm

Addressing limitations with safety and efficacy in solid tumors Tailoring next generation of MTRs for their PK/PD characteristics and tumour uptake Considering treating a broader range of tumors for improved patient benefit through novel targetsRead more

day: Conference Day Two